Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT00180960
Eligibility Criteria:
Inclusion Criteria:
* Peritoneal seedings coming from colon, rectum, pseudomyxoma (appendix), peritoneum (mesothelioma and serous tumors), or endocrine tumors.
* No extra-abdominal metastases
* Good general status (American Society of Anesthesiologists Physical Status score \[ASA\] 1 or 2)
* Signed consent
Exclusion Criteria:
* Tumor seedings coming from other origins
* Huge peritoneal carcinomatosis (peritoneal score \> 25, except for pseudomyxomas)
* Peritoneal carcinomatosis progressing rapidly
* Presence of extra-abdominal metastases
* Patients presenting contraindications to the use of oxaliplatin or irinotecan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00180960
Study Brief:
Protocol Section:
NCT00180960